TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
TRIAL 01-18-4 |
Control material NO. | 01-18-4-1 | 01-18-4-2 | 01-18-4-3 | 01-18-4-4 | Non treponemal test | Reactive | Reactive | Reactive | Reactive | Treponemal test | Reactive | Reactive | Reactive | Reactive | |
|
|
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM |
TRIAL 02-18-4 |
|
Control material NO. | 02-18-4-1 | 02-18-4-2 | 02-18-4-3 | 02-18-4-4 | HBsAg | NEGATIVE 0.59± 0.16(ECLIA) | NEGATIVE 0.56± 0.17(ECLIA) | POSITIVE 2159.10± 279.88 (ECLIA) | POSITIVE 10321.03±1571.49(ECLIA) | antiHBs (all methods) (mIU/ml) | POSITIVE 208.75 ±31.50 | POSITIVE >1000 | NEGATIVE 1.55± 1.87 | NEGATIVE 0.94±1.34 | antiHBc | NEGATIVE | NEGATIVE | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | NEGATIVE | NEGATIVE | NS | NS | |
|
|
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
TRIAL 01-18-3 |
Control material NO. | 01-18-3-1 | 01-18-3-2 | 01-18-3-3 | 01-18-3-4 | Non treponemal test | Reactive | Reactive | Non-Reactive | Reactive | Treponemal test | Reactive | Reactive | Reactive | Reactive | |
|
|
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM |
TRIAL 02-18-3 |
|
Control material NO. | 02-18-3-1 | 02-18-3-2 | 02-18-3-3 | 02-18-3-4 | HBsAg | POSITIVE 1949.42± 195.37(ECLIA) | POSITIVE 9974.84± 1698.38(ECLIA) | NS | NEGATIVE 0.56±0.12(ECLIA) | antiHBs (all methods) (mIU/ml) | NEGATIVE 1.71±0.74 | NEGATIVE 2.04± 0.88 | NEGATIVE 2.39± 0.86 | POSITIVE 1809.27±1577.00 | antiHBc | NEGATIVE | POSITIVE | POSITIVE | NEGATIVE | HBeAg | POSITIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | NEGATIVE | POSITIVE | POSITIVE | NEGATIVE | |
|
|
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |